title: [Massive metrorrhagia in a patient under warfarin anticoagulation. Rapid reversal with a concentrated prothrombin complex (Prothromplex Immuno TIM 4 600 IU)].
authors.forename: M A
authors.initials: MA
authors.lastname: Fuentes Pradera
authors.forename: J M
authors.initials: JM
authors.lastname: Suárez Delgado
authors.forename: G
authors.initials: G
authors.lastname: Yanes Vidal
authors.forename: G
authors.initials: G
authors.lastname: Yerga Pozo
mesh_terms: D000086:Acetazolamide / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000097:blood / Q000150:complications; D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D003244:Consciousness Disorders / Q000209:etiology; D004357:Drug Synergism; D005260:Female; D015812:Glaucoma, Angle-Closure / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007052:Ibuprofen / Q000008:administration & dosage / Q000009:adverse effects; D019934:International Normalized Ratio; D016682:Lupus Coagulation Inhibitor / Q000032:analysis; D008796:Metrorrhagia / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy*; D019851:Thrombophilia / Q000097:blood / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D001779:Blood Coagulation Factors; D016682:Lupus Coagulation Inhibitor; C025667:prothrombin complex concentrates; D014859:Warfarin; D000086:Acetazolamide; D007052:Ibuprofen